Abstract
Objectives:To evaluate the outcomes of clinical pharmacist-led medication therapy management (MTM) services for patients with chronic obstructive pulmonary disease (COPD).Methods:Two hundred COPD patients admitted by the Department of Respiratory and Critical Care Medicine of Baoding No.1 Central Hospital during January 2019 and December 2020 were randomly assigned to a control group (n =100) and an experimental group (n =100). Patients in the control group received conventional treatment, while those in the experimental group were provided with MTM services based on the conventional treatment for comparative analysis of outcome measures, including use of antibacterials during hospital stay, length of stay (LoS), costs of hospitalization (CoH), cases of adverse drug reactions (ADRs), and medication adherence (MA) and COPD assessment test (CAT) score one and six months after discharge.Results:Compared with the control group, the experimental group had reduced use of antibacterials during hospital stay, LoS, CoH, and ADR rate (P <0.05). After discharge, patients in both groups showed remarkable improvements in MA and CAT scores in comparison with their performances upon admission, and the experimental group exhibited better MA and higher CAT score than the control group, with the differences indicating statistical significance (P <0.05).Conclusion:MTM designed for COPD patients can improve pharmacist-led service quality and clinical outcomes of COPD.
Highlights
Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable condition characterized by persistent respiratory symptoms and airflow limitation.[1]
Standard medication and treatment guidelines, effective assessment of patient understanding of treatment plans, Pak J Med Sci November - December 2021 Vol 37 No 7 www.pjms.org.pk 1832 and regular follow-ups are beneficial to patient medication adherence (MA) and therapeutic efficacy by preventing misuse of drugs, reducing medical costs and facilitating rational therapy.[4]
Medication therapy management (MTM) refers to a group of standard services provided by clinical pharmacists, such as pharmacy consulting, medication monitoring, and medication education for patients, to improve MA, address drug-related problems (DRPs) in chronic obstructive pulmonary disease (COPD) cases, optimize therapeutic outcomes and achieve effective disease management with patients.[5]
Summary
Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable condition characterized by persistent respiratory symptoms and airflow limitation.[1]. The Hepler–Strand classification system[6] was employed to classify and analyze DRPs in COPD from the aspects of indications, effectiveness, safety, and MA,[7] aiming to provide strategic guidance for the hospital to improve pharmaceutical care for COPD patients
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
